— Our Products —
Four products. One Strategic Intelligence Engine.
A vertically integrated platform spanning medical affairs, clinical development, translational science, and surgical innovation — engage with one product, or with the whole stack.
ClarezAI MA
Medical Affairs Excellence
Full-suite Medical Affairs function and support — cost-efficient, senior-level expertise without building an entire internal team. True expertise across strategy, evidence, communications, congress, and KOL engagement.
Open full ClarezAI MA page →Full-Suite Capabilities
- Medical Affairs Strategy
- Medical Communication
- Scientific Publications
- New Evidence Insights
- Education & Training
- Congress Strategy & Presence
- Advisory Board Management
- KOL Engagement & Network Activation
- Cost-Efficient Operating Model
CASExAI
Clinical Trial Efficiency & Performance
An AI-driven platform that streamlines patient identification, enrollment, engagement, and retention — featuring SKYE (AI-powered study coordinator assistant) and SARA (Patient-Related Outcomes mobile app).
Open full CASExAI page →Platform Modules
- Clinical Trial Management System (CTMS)
- Efficiency from screening to enrollment
- Acceleration of enrollment
- SKYE — AI-powered study coordinator assistant
- SARA — Patient-Related Outcomes (ePROs) mobile app
- Mobile Retina Clinic integration
- Clinical site engagement tools
- Referral and recruitment programs
NRSS
Near-Real Surgical Systems
An AI-powered Near-Real Human Eye Model that bridges the gap between laboratory research and clinical application — reducing development risk and improving translational success through a realistic preclinical environment.
Open full NRSS page →Platform Modules
- Concept-to-validation testing
- Pharmacokinetic / Pharmacodynamic (PK/PD) modeling
- Drug distribution modeling
- Dose optimization studies
- Surgical training and assessment
ClinomicsAI
Deep Proteomic Analysis & Bioinformatics
Minimally invasive liquid biopsy proteomics built on Stanford University IP (developed and licensed) — generating real-time molecular insights that inform precision medicine and patient stratification.
Open full ClinomicsAI page →Analytical Capabilities
- Real-time molecular insights (on-target & off-target)
- Identification of drug-sensitive pathways
- Efficacy pathway elucidation
- Safety pathway identification
- Patient response to treatment prediction
- Patient population selection & stratification
— Strategic Value Proposition —
An end-to-end ecosystem across the entire product lifecycle.
From scientific discovery and biomarker identification to clinical development, medical affairs execution, and real-world implementation — by combining AI, translational science, and domain expertise, ClarezAI enables biotechnology and pharmaceutical organizations to:
- Accelerate drug development timelines
- Reduce operational and development costs
- Improve clinical trial success rates
- Generate actionable scientific insights
- Enhance patient selection and treatment outcomes
- Scale medical affairs capabilities efficiently
— Let's Work Together —
Ready to unlock the full strategic value of your science?
Tell us where you are in development and what you're trying to achieve. We'll follow up to explore how ClarezAI can help.